You have free access to this content

Clinical Liver Disease

© 2013 The American Association for the Study of Liver Diseases

Cover image for Clinical Liver Disease

Special Issue: Hepatitis C Infection – Treatment Part 2

April 2012

Volume 1, Issue 2

Pages 29–61

Issue edited by: Marc G. Ghany, M.D., M.H.Sc.

  1. Reviews

    1. Top of page
    2. Reviews
    1. You have free access to this content
      Issues in selecting HCV-infected candidates for anti-viral treatment (pages 29–31)

      Anna S. Lok

      Article first published online: 26 APR 2012 | DOI: 10.1002/cld.18

    2. You have free access to this content
      Is there still a role for liver biopsy in managing hepatitis C virus infections? (pages 32–35)

      Syed-Mohammed R. Jafri and Stuart C. Gordon

      Article first published online: 26 APR 2012 | DOI: 10.1002/cld.30

    3. You have free access to this content
      Managing drug-drug interactions with boceprevir and telaprevir (pages 36–40)

      Amol S. Rangnekar and Robert J. Fontana

      Article first published online: 26 APR 2012 | DOI: 10.1002/cld.10

    4. You have free access to this content
      Importance of patient education and monitoring among HCV-infected patients selected for anti-viral treatment (pages 41–45)

      Corinne Wentworth-Kotara and P.A-C.

      Article first published online: 26 APR 2012 | DOI: 10.1002/cld.9

    5. You have free access to this content
      Predicting the response to the treatment of hepatitis C virus infection (pages 46–48)

      David L. Thomas

      Article first published online: 26 APR 2012 | DOI: 10.1002/cld.11

    6. You have free access to this content
      Treatment options for anti-HCV treatment-experienced patients (pages 49–50)

      Peter Ferenci

      Article first published online: 26 APR 2012 | DOI: 10.1002/cld.29

    7. You have free access to this content
      HCV infection on-treatment viral kinetics: Do they still have a role? (pages 51–53)

      Jordan J. Feld

      Article first published online: 26 APR 2012 | DOI: 10.1002/cld.36

    8. You have free access to this content
      Management of adverse events during the treatment of chronic hepatitis C infection (pages 54–57)

      Douglas L. Nguyen and Timothy R. Morgan

      Article first published online: 26 APR 2012 | DOI: 10.1002/cld.33

    9. You have free access to this content
      Drug resistance: Prevalence and clinical implications during the treatment of chronic hepatitis C infection (pages 58–61)

      Jean-Michel Pawlotsky

      Article first published online: 26 APR 2012 | DOI: 10.1002/cld.8

SEARCH

SEARCH BY CITATION